
Probiotical Expands Beyond Gut Health With Vaginal and Allergy Product Launches
Key Takeaways
- Vaginal wellness expansion is exemplified by a single-strain, clinically studied probiotic capsule positioned to restore vaginal microbiome balance via a 3-day protocol.
- Allergy and seasonal wellness products integrate multi-strain pre-/probiotic blends into diverse delivery formats, including fast-dissolving oral strips, with mass-market retail placement.
The ingredient manufacturer's ingredients now appear in a vaginal microbiome capsule and an allergy oral strip, signaling broader category use for pro- and postbiotics.
Probiotical S.p.A., a probiotic and postbiotic ingredient supplier and manufacturer, announced on September 22, 2026, that it is spotlighting two consumer products built on its microbial ingredients.1 The company presents the launches as examples of probiotics and postbiotics moving into wellness categories beyond digestive health.
What Are the Two Launches?
The first product launch targets vaginal wellness with DARE to RESTORE Flora Sync LF5, a vaginal probiotic capsule marketed by Daré Bioscience. According to Probiotical, the product was designed and clinically studied to restore vaginal microbiome balance and is used in a 3-day protocol. The company describes the formula as single-strain.
The second launch offers a line of products for the allergy care space. Wizard Wellness offers steroid-free oral strips, sinus rinses, and sprays for allergy and seasonal wellness. The release notes distribution through Target, Walmart, and CVS. Probiotical says the line uses multi-strain pre- and probiotic blends, including in fast-dissolving oral strips, combined with complementary ingredients.
How Does Probiotical Approach Product Development?
Probiotical reports a collection of more than 2,000 microbial strains, with over 60 in commercial production. The company says this range lets developers choose among single-strain products, proprietary multi-strain blends, and formulations that pair probiotics with prebiotics, botanicals, minerals, or other ingredients.
For multi-strain formulas, Probiotical states that its research and development process reviews strain identity and function, compatibility between strains, compatibility with other actives, dosage, processing conditions, viability through shelf life, and stability in the finished format and packaging. The company contrasts this with generic strain selection or reliance on a general CFU count.
Who Is Leading Probiotical’s North American Growth?
Probiotical recently hired Keith Dunne as director of market expansion for North America. He previously served as general manager and vice president of sales and marketing at American River Nutrition. Dunne highlighted how the company's development model can support brands. “Probiotical’s ‘white-glove’ development model supports customers throughout the product development journey,” explained Dunne. “Our integrated model gives emerging brands access to the microbial research, scientific personnel, and manufacturing capabilities typically associated with much larger organizations, along with the expertise in strain selection, multi-strain compatibility, stability, delivery, and scale-up needed to translate an idea into a differentiated commercial product.”
What Does Probiotical Say About Its Capabilities?
Probiotical's main site describes a vertically integrated model spanning strain isolation and clinical research, raw-material and finished-good production, and custom formulation for individual brands.2 The company organizes its offerings into three lines: strains and blends sold as raw material and in finished products, market-ready formulations validated for private labeling, and fully tailored probiotic and synbiotic products built to a customer's specifications.
The site also describes several manufacturing methods, including microencapsulation technology enabling the production of individually coated probiotic bacteria, allergen-free production processes intended to exclude allergens named in European and U.S. regulations, an oil-suspension format the company says supports 18- to 24-month shelf stability at room temperature, and flow cytometry for bacterial cell counting.
Probiotical lists several therapeutic areas it develops for, including gynecology and allergy and immunology, the two categories represented by the Daré Bioscience and Wizard Wellness launches, alongside areas such as gastroenterology, dermatology, oral care, and pediatrics. The company states it was founded in 1985 in Novara, Italy, building seven decades of experience in microbial science. It explains that its mission is to revolutionize human health through probiotic innovation while becoming a global, evidence-based industry leader.3
References
- Probiotical S.p.A. Probiotical spotlights two category-expanding microbiome consumer product launches signaling a new direction in pro- and postbiotic health. Press release. September 22, 2026. Accessed September 29, 2026.
- Probiotical S.p.A. Accessed September 29, 2026.
https://www.probiotical.com/ - Probiotical S.p.A. Accessed September 29, 2026.
https://www.probiotical.com/en/about/
Related to this article









